Lab-Grown cells could unlock new kidney disease treatments

NCT ID NCT06718894

Recruiting now Knowledge-focused Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Source: ClinicalTrials.gov ↗

First seen Apr 01, 2026 · Last updated May 12, 2026 · Updated 7 times

Summary

This study aims to see if a lab-grown cell system can detect a substance in the blood that causes protein leakage in the urine of people with a kidney condition called nephrotic syndrome. Researchers will compare blood and urine samples from 150 participants—including those with the condition, healthy volunteers, and people with other kidney diseases—over up to 36 months. The system will also be used to test whether a combination of drugs can stop the protein leakage in the lab.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
RECRUITING

Milan, 20122, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
Fondazione IRCCS Policlinico San Matteo
RECRUITING

Pavia, Italy

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

NEPHROTIC SYNDROME